Back
Zenas BioPharma, Inc. 10K Form
Sell
50
ZBIO
Zenas BioPharma, Inc.
Last Price:
$38.11
Seasonality Move:
-4.38%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ZBIO News And Ratings
See the #1 stock for the next 7 days that we like better than ZBIO
ZBIO Financial Statistics
Sales & Book Value
| Annual Sales: | $5M |
|---|---|
| Cash Flow: | $-41.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.65 |
| Price / Book: | 7.81 |
Profitability
| EPS (TTM): | -4.53080 |
|---|---|
| Net Income (TTM): | $-189.9M |
| Gross Margin: | $4.9M |
| Return on Equity: | -68.2% |
| Return on Assets: | -55.13% |
Zenas BioPharma, Inc. Earnings Forecast
Key Zenas BioPharma, Inc. Financial Ratios
-
The Gross Profit Margin over the past 3 years for ZBIO is 97.26%.
-
The Selling, General & Administrative Expenses for ZBIO have been equal to 594.98% of Gross Profit Margin.
-
The Research & Development expenses have been 2,782.78% of Revenue.
-
The Net Earning history of ZBIO is -3,139.76% of Total Revenues.
-
Per Share Earnings over the last 3 years have been positive in 1 years.
Zenas BioPharma, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ZBIO |
| CUSIP: | 74347B |
| Website: | zenasbio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 5.66 |
| Quick Ratio: | 5.55 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ZBIO Technical Analysis vs Fundamental Analysis
Sell
50
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy or a Sell?
-
Zenas BioPharma, Inc. stock is rated a SellThe current Zenas BioPharma, Inc. [ZBIO] share price is $38.11. The Score for ZBIO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.